<?xml version='1.0' encoding='utf-8'?>
<document id="26552146"><sentence text="[The interactions between natural products and OATP1B1]." /><sentence text="Organic anion transporting polypeptide 1B1 (OATP1B1) is an important liver-specific uptake transporter, which mediates transport of numerous endogenous substances and drugs from blood into hepatocytes" /><sentence text=" To identify and investigate potential modulators of OATP1B1 from natural products, the effect of 21 frequently used natural compounds and extracts on OATP1B1-mediated fluorescein methotrexate transport was studied by using Chinese hamster ovary cells stably expressing OATP1B1 (CHO-OATP1B1) in 96-well plates"><entity charOffset="168-192" id="DDI-PubMed.26552146.s3.e0" text="fluorescein methotrexate" /></sentence><sentence text=" This method could be used for the screening of large compound libraries" /><sentence text=" Our studies showed that some flavonoids (e"><entity charOffset="30-40" id="DDI-PubMed.26552146.s5.e0" text="flavonoids" /></sentence><sentence text="g" /><sentence text=", quercetin, quercitrin, rutin, chrysanthemum flavonoids and mulberrin) and triterpenoids (e"><entity charOffset="2-11" id="DDI-PubMed.26552146.s7.e0" text="quercetin" /><entity charOffset="13-23" id="DDI-PubMed.26552146.s7.e1" text="quercitrin" /><entity charOffset="25-30" id="DDI-PubMed.26552146.s7.e2" text="rutin" /><entity charOffset="46-56" id="DDI-PubMed.26552146.s7.e3" text="flavonoids" /><entity charOffset="61-70" id="DDI-PubMed.26552146.s7.e4" text="mulberrin" /><entity charOffset="76-89" id="DDI-PubMed.26552146.s7.e5" text="triterpenoids" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e0" e2="DDI-PubMed.26552146.s7.e0" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e0" e2="DDI-PubMed.26552146.s7.e1" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e0" e2="DDI-PubMed.26552146.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e0" e2="DDI-PubMed.26552146.s7.e3" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e0" e2="DDI-PubMed.26552146.s7.e4" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e0" e2="DDI-PubMed.26552146.s7.e5" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e1" e2="DDI-PubMed.26552146.s7.e1" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e1" e2="DDI-PubMed.26552146.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e1" e2="DDI-PubMed.26552146.s7.e3" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e1" e2="DDI-PubMed.26552146.s7.e4" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e1" e2="DDI-PubMed.26552146.s7.e5" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e2" e2="DDI-PubMed.26552146.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e2" e2="DDI-PubMed.26552146.s7.e3" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e2" e2="DDI-PubMed.26552146.s7.e4" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e2" e2="DDI-PubMed.26552146.s7.e5" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e3" e2="DDI-PubMed.26552146.s7.e3" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e3" e2="DDI-PubMed.26552146.s7.e4" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e3" e2="DDI-PubMed.26552146.s7.e5" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e4" e2="DDI-PubMed.26552146.s7.e4" /><pair ddi="false" e1="DDI-PubMed.26552146.s7.e4" e2="DDI-PubMed.26552146.s7.e5" /></sentence><sentence text="g" /><sentence text=", glycyrrhetinic acid and glycyrrhizic acid) were inhibitors of OATP1B1 with IC50 values less than 16 µmol · L(-1)"><entity charOffset="2-21" id="DDI-PubMed.26552146.s9.e0" text="glycyrrhetinic acid" /><entity charOffset="26-43" id="DDI-PubMed.26552146.s9.e1" text="glycyrrhizic acid" /><pair ddi="false" e1="DDI-PubMed.26552146.s9.e0" e2="DDI-PubMed.26552146.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26552146.s9.e0" e2="DDI-PubMed.26552146.s9.e1" /></sentence><sentence text=" The IC50 value of glycyrrhetinic acid on OATP1B1 was comparable to its blood concentration in clinics, indicating an OATPlB1-mediated drug-drug interaction could occur"><entity charOffset="19-38" id="DDI-PubMed.26552146.s10.e0" text="glycyrrhetinic acid" /></sentence><sentence text=" Structure-activity relationship analysis showed that flavonoids had much higher inhibitory activity than their glycosides"><entity charOffset="54-64" id="DDI-PubMed.26552146.s11.e0" text="flavonoids" /><entity charOffset="112-122" id="DDI-PubMed.26552146.s11.e1" text="glycosides" /><pair ddi="false" e1="DDI-PubMed.26552146.s11.e0" e2="DDI-PubMed.26552146.s11.e0" /><pair ddi="false" e1="DDI-PubMed.26552146.s11.e0" e2="DDI-PubMed.26552146.s11.e1" /></sentence><sentence text=" Furthermore, the type and length of saccharides had a significant effect on their activity" /><sentence text=" In addition, we used OATP1B1 substrates fluvastatin and rosuvastatin as probe drugs to investigate the substrate-dependent effect of several natural compounds on the function of OATP1B1 in vitro"><entity charOffset="41-52" id="DDI-PubMed.26552146.s13.e0" text="fluvastatin" /><entity charOffset="57-69" id="DDI-PubMed.26552146.s13.e1" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.26552146.s13.e0" e2="DDI-PubMed.26552146.s13.e0" /><pair ddi="false" e1="DDI-PubMed.26552146.s13.e0" e2="DDI-PubMed.26552146.s13.e1" /></sentence><sentence text=" Our results demonstrated that the effect of these natural products on the function of OATPlB1 was substrate-dependent" /><sentence text=" In summary, this study would be conducive to predicting and avoiding potential OATP1B1-mediated drug-drug and drug-food interactions and thus provide the experimental basis and guidance for rational drug use" /><sentence text="" /></document>